Ali Urman, Genomics Analyst, ARK Invest joins us to discuss the technological revolution that is taking place in the field of genomics and biotechnology and the companies leading the foray into what will be the future of health care and medical treatment.
We talk to Lisa Lake Langley, CEO of Emerge Canada Inc. about the ETFs her company launched in Mid 2019, among which is EAGB, the Emerge ARK Genomics and Biotech ETF, which is sub-advised by ARK Invest.